Breaking News, Collaborations & Alliances

Samsung Bioepis Opens New Headquarters

The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-gen biologic medicines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Samsung Bioepis, a joint venture between Samsung Biologics and Biogen, has opened its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone (IFEZ), a specially-designated economic zone in the city of Incheon. The new site is approximately 52,000 square feet, and will be the hub of Samsung Bioepis’ drive for development of next-generation biologic medicines. Construction of the new building was completed in December 2020.   “We are very excited to be openi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters